Who should not take the Pfizer-BioNTech COVID-19 vaccine?
If you have had a severe allergic reaction to any ingredient in the Pfizer-BioNTech COVID-19 vaccine (such as polyethylene glycol), you should not get this vaccine. If you had a severe allergic reaction after getting a dose of the Pfizer-BioNTech COVID-19 vaccine, you should not get another dose of an mRNA vaccine.
Children younger than age 5 years are not eligible to receive the Pfizer-BioNTech COVID-19 Vaccine at this time unless part of a clinical trial. Children and adolescents younger than age 18 years are not eligible to receive the Moderna or Janssen COVID-19 vaccines at this time.
People with underlying medical conditions can receive a COVID-19 vaccine as long as they have not had an immediate or severe allergic reaction to a COVID-19 vaccine or to any of the ingredients in the vaccine. Learn more about vaccination considerations for people with underlying medical conditions. Vaccination is an important consideration for adults of any age with certain underlying medical conditions because they are at increased risk for severe illness from COVID-19.
Patients with chronic liver disease can receive the COVID-19 vaccine as soon as it is available to them. Although the immunogenicity of vaccines has not been fully described in this population, vaccination has been associated with lower risk of COVID-19 in patients with cirrhosis.
• COVID-19 vaccines are safe and effective.
• Millions of people in the United States have received COVID-19 vaccines under the most intense safety monitoring in U.S. history.
• CDC recommends you get a COVID-19 vaccine as soon as possible.
COVID-19 vaccines are safe and effective. COVID-19 vaccines were evaluated in tens of thousands of participants in clinical trials.
The most commonly reported side effects were pain at the injection site, tiredness, headache, muscle pain, chills, joint pain, nausea and vomiting, swollen lymph nodes in the same arm of the injection and fever. Side effects typically started within two days of vaccination and resolved two or three days later.
If you have had a severe allergic reaction (anaphylaxis) or an immediate allergic reaction, even if it was not severe, to any ingredient in the J&J/Janssen COVID-19 Vaccine (such as polysorbate), you should not get the J&J/Janssen COVID-19 Vaccine.
The American College of Rheumatology COVID-19 Vaccine Clinical Guidance recommends that people with autoimmune and inflammatory rheumatic disease (which includes lupus) get the vaccine unless they have an allergy to an ingredient in the vaccine.
Primary Series Shots People who are immunocompromised are especially vulnerable to COVID-19. Everyone, including immunocompromised people, should receive a COVID-19 vaccine primary series if they are 5 years and older as soon as possible.
Researchers have reported higher rates of severe COVID-19 and death in people with autoimmune disease than in the general population. It is unclear whether this is attributable to the autoimmune disease, the immunosuppressive medications taken to treat it, or both.
Having heart conditions such as heart failure, coronary artery disease, cardiomyopathies, and possibly high blood pressure (hypertension) can make you more likely to get severely ill from COVID-19.
Hypertension is more frequent with advancing age and among non-Hispanic blacks and people with other underlying medical conditions such as obesity and diabetes. At this time, people whose only underlying medical condition is hypertension might be at increased risk for severe illness from COVID-19.
July 21, 2021 -- The Obesity Society -- the leading American organization of experts devoted to understanding and treating obesity -- is urging all people with obesity to go get any of the approved COVID-19 vaccines as soon as possible if they have not already done so.
The FDA gave the Pfizer-BioNTech COVID-19 vaccine emergency authorization to use in children ages 5 years through 15 years old and full approval to use in people ages 16 years and older. Learn more about the process of developing, authorizing and approving COVID-19 vaccines.
1. The Moderna COVID-19 Vaccine is authorized for use in individuals 18 years of age and older.
There is a risk that flare-ups may occur. That being said, it has been observed that people living with autoimmune and inflammatory conditions are at higher risk of experiencing severe symptoms from a COVID-19 infection.
The CDC and the ACR recommend that people with lupus and other autoimmune conditions get the vaccine and a booster shot or third dose if necessary. Studies have also shown that the vaccine generally does not lead to increased disease activity in people with lupus.
If you have rheumatoid arthritis (RA), you're more likely to get certain infections. That means you may have a higher chance of getting COVID-19. If you do get sick, your symptoms could be more serious than someone who doesn't have RA.
The most commonly reported side effects were pain at the injection site, headache, fatigue, muscle aches and nausea. Most of these side effects occurred within 1-2 days following vaccination and were mild to moderate in severity and lasted 1-2 days.
The J&J/Janssen COVID-19 Vaccine is recommended for people 18 years and older.
If you have had a severe allergic reaction or an immediate allergic reaction to any ingredient in Johnson & Johnson’s Janssen (J&J/Janssen) COVID-19 vaccine, you should not get the J&J/Janssen vaccine.
Side effects after your second shot may be more intense than the ones you experienced after your first shot. These side effects are normal signs that your body is building protection and should go away within a few days.
Fever, headache, fatigue and pain at the injection site were the most commonly reported side effects, and overall, most side effects were mild to moderate. However, as with the two-dose or single-dose primary series, serious side effects are rare, but may occur.
2. None of the reactions arose at the time of vaccination. The skin reaction appeared anywhere from two to 12 days after the first Moderna shot, with a median latency to onset of seven days.
3. The arm reaction lasted for a median of five days, but could persist for up to 21 days.